NCK1-AS1 might affect ESCC cell metastasis by regulating TGF-β1 expression, suggesting that NCK1-AS1 may be a potential prognostic biomarker and novel therapeutic target for ESCC. Here, NCK1 is linked to esophageal squamous cell carcinoma.